Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM)
24.97
-0 (-0%)
| Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $24.97 | 52 Week High | $24.97 | ||
| Open | $24.97 | 52 Week Low | $24.97 | ||
| Day High | $24.97 | P/E | 227.00 | ||
| Day Low | $24.97 | EPS | $0.11 | ||
| Volume | 0 | ||||
| More MLNM Info: Chart SEC Filings Profile Historical Options | |||||
Millennium Pharmaceuticals Summary
Millennium Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of medicines for cancer and inflammatory diseases. It markets VELCADE (bortezomib) for injection in the relapsed multiple myeloma and relapsed non-Hodgkin's lymphoma settings.
Executives
Dr. Deborah Dunsire M.D. - CEO, President
Dr. Raju Kucherlapati Ph.D. - Founder, Director, Chairman
Links
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| MNT | 2 | TEVA | 2 |
| ERTS | 2 | BRL | 2 |
| CPN | 2 | OMRI | 2 |
| ERTS | 2 | ALO | 2 |
| SNDK | 2 | KG | 2 |
| ALO | 2 | SNDK | 2 |
Entities who have mentioned MLNM
- JPMorgan | View Related Stories »
- Merrill Lynch | View Related Stories »
- Bear Stearns | View Related Stories »
- Banc of America | View Related Stories »
- Robert W Baird | View Related Stories »
- Lehman Brothers | View Related Stories »
- UBS | View Related Stories »
- Morgan Stanley | View Related Stories »
- Bankruptcy | View Related Stories »
- Piper Jaffray | View Related Stories »
- Credit Suisse | View Related Stories »
- Wachovia | View Related Stories »
- Bain Capital | View Related Stories »
- Wellspring Capital Management | View Related Stories »
- Ben S. Bernanke | View Related Stories »
- Hellman & Friedman LLC | View Related Stories »
- Barclays | View Related Stories »
- Apollo Management | View Related Stories »
- Aurora Capital Group | View Related Stories »
- BMO Capital | View Related Stories »
- Piper Jaffray Alpha List | View Related Stories »
- Jefferies & Co | View Related Stories »
- Soleil Securities | View Related Stories »
- Keefe, Bruyette & Woods | View Related Stories »
- Deutsche Bank | View Related Stories »
StreetInsider Reports on MLNM by Category
View All BlogsBlogs on MLNM
- Market highlights for next week: Lehman Brothers and Morgan Stanley reporting earnings
- Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
- Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom
- Why GlaxoSmithKline Will Leave Sirtris Well Alone
- General Electric's Healthcare Disappointment
Comments on recent MLNM articles
Comments on MLNM
No comments are currently available.
on Jun 4, 2009
at 08:32 PM classified info Hi are you the owner of the car company anor if so i would like the list of people that baot it i am at mi dad's so my email adress is michael.sharon@sympatico.ca
Article: SuttonBrook Capital Makes Good In AnorMED (ANOR) Investment
on Jan 2, 2009
at 03:04 PM Despite Lehman failure... Hats off to the Wall Street gurus who pulled off deals despite the carnage for example Teva's successful takeover of Barr was represented by Lehman until the venerable finance house went belly up. Nevertheless the deal close on time.
Article: Top 15 For 2008 (No. 14): M&A Wreckage